Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Haematol ; 132(2): 134-9, 2014.
Article in English | MEDLINE | ID: mdl-24556628

ABSTRACT

We report the cases of 3 patients with hematological malignancies and complex karyotypes involving der(5; 17) (p10;q10), which results in the loss of 5q and 17p. Although deletions of 5q and 17p are recurrent abnormalities in hematological disease, only about 20 cases harboring der(5; 17) (p10;q10) have been reported. We address the tumorigenesis and morphological characteristics of hematological malignancies involving der(5; 17)(p10;q10), along with a review of the literature.


Subject(s)
Chromosomes, Human, Pair 17/ultrastructure , Chromosomes, Human, Pair 5/ultrastructure , Hematologic Neoplasms/genetics , Translocation, Genetic , Aged , Aged, 80 and over , Anemia, Refractory, with Excess of Blasts/drug therapy , Anemia, Refractory, with Excess of Blasts/genetics , Anemia, Refractory, with Excess of Blasts/pathology , Aneuploidy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow Cells/ultrastructure , Cell Transformation, Neoplastic/genetics , Chromosome Aberrations , Chromosome Banding , Contraindications , Fatal Outcome , Female , Hematologic Neoplasms/pathology , Humans , Karyotype , Lenalidomide , Leukemia, Myelomonocytic, Chronic/genetics , Leukemia, Myelomonocytic, Chronic/pathology , Lymphoma, T-Cell, Peripheral/drug therapy , Male , Megakaryocytes/ultrastructure , Myelodysplastic Syndromes/genetics , Myelodysplastic Syndromes/pathology , Neoplasms, Second Primary/genetics , Neoplasms, Second Primary/pathology , Recurrence , Remission Induction , Thalidomide/analogs & derivatives
SELECTION OF CITATIONS
SEARCH DETAIL
...